Lab Information

Matthew Cheng (MD)

Junior Scientist
Centre for Translational Biology
Department of Medicine (McGill)

Research Profile

 Fundamental: 40%
 Clinical: 60%
 Epidemiology: 0%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

Lethal infectious diseases • opportunistic infections • sepsis • bacteremia

Research Interests

My research focuses on patients with potentially lethal infections, including those with severe manifestations of sepsis, bloodstream infections, and opportunistic infections in immunocompromised hosts. My research program aims to improve morbidity and mortality in these conditions by discovering original treatment strategies through avant-garde clinical trials. I also develop novel diagnostic assays to improve outcomes in these patients, such as using plasma cell-free DNA to monitor the host response to infection and optimize treatment decisions.


Team Members

Name Position

Latest Publications

  1. Prosty, C., Katergi, K., Nguyen, A., Luo, O. D., Sorin, M., Cherniak, V., Sebag, M., Demir, K., McDonald, E. G., Lee, T. C. & Cheng, M. P. (2024). Infectious Complications of Venetoclax Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis. Blood advances, vol. 8, p. 857-866.
  2. Mohammed, Y., Tran, K., Carlsten, C., Ryerson, C., Wong, A., Lee, T., Cheng, M. P., Vinh, D. C., Lee, T. C., Winston, B. W., Sweet, D., Boyd, J. H., Walley, K. R., Haljan, G., McGeer, A., Lamontagne, F., Fowler, R., Maslove, D., Singer, J., Patrick, D. M., Marshall, J. C., Murthy, S., Jain, F., Borchers, C. H., Goodlett, D. R., Levin, A., Russell, J. A. & ARBs CORONA I Consortium (2024). Proteomic Evolution from Acute to Post-COVID-19 Conditions. Journal of proteome research, vol. 23, p. 52-70.
  3. de Kretser, D., Mora, J., Bloomfield, M., Campbell, A., Cheng, M. P., Guy, S., Hensgens, M., Kalimuddin, S., Lee, T. C., Legg, A., Mahar, R. K., Marks, M., Marsh, J., McGlothlin, A., Morpeth, S. C., Sud, A., Ten Oever, J., Yahav, D., Tong, S. Y., Davis, J. S., Walls, G., Goodman, A. L., Bonten, M. & Staphylococcus aureus Network Adaptive Platform (SNAP) Study Group members (2023). Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
  4. Lieu, A., Lee, T. C., Lawandi, A., Tellier, R., Cheng, M. P. & Dufresne, P. J. (2023). Microbiological characterization of Pneumocystis jirovecii pneumonia using quantitative PCR from nasopharyngeal specimens: a retrospective study in a Canadian province from 2019 to 2023. Journal of clinical microbiology, p. e0091323.
  5. Camirand Lemyre, F., Honfo, S. H., Caya, C., Cheng, M. P., Colwill, K., Corsini, R., Gingras, A.-C., Jassem, A., Krajden, M., Márquez, A. C., Mazer, B. D., McLennan, M., Renaud, C., Yansouni, C. P., Papenburg, J. & Lewin, A. (2023). Two-phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID-19 serological assays as a proof of concept. Vox sanguinis, vol. 118, p. 1069-1077.
  6. Lee, T., Cheng, M. P., Vinh, D. C., Lee, T. C., Tran, K. C., Winston, B. W., Sweet, D., Boyd, J. H., Walley, K. R., Haljan, G., McGeer, A., Lamontagne, F., Fowler, R., Maslove, D. M., Singer, J., Patrick, D. M., Marshall, J. C., Burns, K. D., Murthy, S., Mann, P. K., Hernandez, G., Donohoe, K., Russell, J. A. & for ARBs CORONA I (2023). Outcomes and characteristics of patients hospitalized for COVID-19 in British Columbia, Ontario and Quebec during the Omicron wave. CMAJ open, vol. 11, p. E672-E683.
  7. Cheng, M. P., Paquette, K., Lawandi, A., Stabler, S. N., Akhter, M., Davidson, A. C., Gavric, M., Jinah, R., Saeed, Z., Demir, K., Sangsari, S., Huang, K., Mahpour, A., Shamatutu, C., Caya, C., Troquet, J.-M., Clark, G., Rush, B., Wong, T., Stenstrom, R., Sweet, D. & Yansouni, C. P. (2022). qSOFA does not predict bacteremia in patients with severe manifestations of sepsis. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 364-368.
  8. Hadid, A., McDonald, E. G., Cheng, M. P., Papenburg, J., Libman, M., Dixon, P. C. & Jensen, D. (2023). The WE SENSE study protocol: A controlled, longitudinal clinical trial on the use of wearable sensors for early detection and tracking of viral respiratory tract infections. Contemporary clinical trials, vol. 128, p. 107103.
  9. Malhamé, I., Hardy, E., Cheng, M. P., Tong, S. Y. & Bowen, A. C. (2023). Walking the walk to include pregnant participants in non-obstetric clinical trials: Insights from the SNAP Trial. Obstetric medicine, vol. 16, p. 3-4.
  10. Henderson, A., Cheng, M. P., Chew, K. L., Coombs, G. W., Davis, J. S., Grant, J. M., Gregson, D., Giulieri, S. G., Howden, B. P., Lee, T. C., Nguyen, V., Mora, J. M., Morpeth, S. C., Robinson, J. O., Tong, S. Y. C., Van Hal, S. J. & Microbiology Working Group of the Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Group (2023). A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus. The Journal of antimicrobial chemotherapy, vol. 78, p. 1499-1504.
More on PubMed 



See also

Card image
Todd
Lee


See profile
Card image
Emily
McDonald


See profile
Card image
Cédric
Yansouni


See profile
Card image
Alexander
Lawandi


See profile
Card image
Jesse
Papenburg


See profile
Card image
Donald
Vinh


See profile